Citigroup Cuts Keurig Dr Pepper (NASDAQ:KDP) Price Target to $37.00

Key Points

• Citigroup has lowered its price target for Keurig Dr Pepper from $41.00 to $37.00, while maintaining a "buy" rating on the stock, indicating a potential upside of 38.32% from the previous close.
• Other analysts have also adjusted their targets for Keurig Dr Pepper, with UBS and Deutsche Bank lowering their target prices to $35.00 and $38.00 respectively, while still retaining "buy" ratings.
• The company reported quarterly earnings of $0.49 per share, meeting analysts' expectations, along with a revenue of $4.16 billion, marking a 6.1% increase compared to the same quarter last year.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) had its price target dropped by equities research analysts at Citigroup from $41.00 to $37.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. Citigroup's target price indicates a potential upside of 38.32% from the company's previous close.

A number of other research analysts have also commented on KDP. UBS Group cut their price target on Keurig Dr Pepper from $40.00 to $35.00 and set a "buy" rating for the company in a report on Wednesday, August 27th. Deutsche Bank Aktiengesellschaft cut their target price on Keurig Dr Pepper from $40.00 to $38.00 and set a "buy" rating for the company in a research note on Tuesday, August 26th. JPMorgan Chase & Co. cut their target price on Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating for the company in a research note on Thursday, July 17th. Jefferies Financial Group set a $41.00 target price on Keurig Dr Pepper in a research note on Monday, August 25th. Finally, Barclays upped their target price on Keurig Dr Pepper from $37.00 to $39.00 and gave the company an "overweight" rating in a research note on Monday, July 28th. Eleven analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, Keurig Dr Pepper presently has an average rating of "Moderate Buy" and a consensus target price of $38.15.

Keurig Dr Pepper Stock Down 1.8%

Shares of KDP stock opened at $26.75 on Tuesday. Keurig Dr Pepper has a 12 month low of $26.69 and a 12 month high of $38.28. The firm has a market cap of $36.34 billion, a PE ratio of 23.88, a price-to-earnings-growth ratio of 1.49 and a beta of 0.47. The stock has a 50 day moving average of $32.20 and a 200-day moving average of $33.21. The company has a quick ratio of 0.40, a current ratio of 0.64 and a debt-to-equity ratio of 0.56.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The company reported $0.49 EPS for the quarter, hitting analysts' consensus estimates of $0.49. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The company had revenue of $4.16 billion during the quarter, compared to analyst estimates of $4.14 billion. During the same period in the previous year, the company earned $0.45 earnings per share. The company's quarterly revenue was up 6.1% compared to the same quarter last year. On average, equities analysts predict that Keurig Dr Pepper will post 1.92 EPS for the current year.

Insider Buying and Selling at Keurig Dr Pepper

In other Keurig Dr Pepper news, Director Robert James Gamgort sold 208,000 shares of the stock in a transaction on Friday, August 1st. The stock was sold at an average price of $32.90, for a total transaction of $6,843,200.00. Following the completion of the transaction, the director directly owned 2,292,169 shares in the company, valued at $75,412,360.10. This represents a 8.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Mary Beth Denooyer sold 12,000 shares of the stock in a transaction on Thursday, July 17th. The stock was sold at an average price of $33.66, for a total value of $403,920.00. Following the transaction, the insider owned 82,511 shares of the company's stock, valued at $2,777,320.26. This represents a 12.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 459,601 shares of company stock valued at $15,228,872 over the last quarter. Corporate insiders own 1.00% of the company's stock.

Institutional Trading of Keurig Dr Pepper

Large investors have recently made changes to their positions in the business. Rise Advisors LLC bought a new stake in shares of Keurig Dr Pepper during the first quarter worth $25,000. Chung Wu Investment Group LLC bought a new stake in shares of Keurig Dr Pepper during the second quarter worth $26,000. NewSquare Capital LLC grew its holdings in shares of Keurig Dr Pepper by 94.1% during the second quarter. NewSquare Capital LLC now owns 796 shares of the company's stock worth $26,000 after purchasing an additional 386 shares during the last quarter. AlphaCore Capital LLC bought a new stake in shares of Keurig Dr Pepper during the second quarter worth $26,000. Finally, ST Germain D J Co. Inc. bought a new stake in shares of Keurig Dr Pepper during the first quarter worth $27,000. Institutional investors own 93.99% of the company's stock.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.